10.1074/jbc.M308035200 37 FujiwaraS.KawazoeT.OhnishiK.KitagawaT.PopaC.VallsM.et al (2016)
Within this blend, CJC-1295 (No DAC) and Tesamorelin together constitute a dual GHRH receptor stimulation platform two structurally differentiated analogs engaging the same receptor class through overlapping but not identical binding kinetics, providing investigators with a richer model of GHRH receptor pharmacodynamics than either compound delivers independently
Peptides that influence growth hormone release, IGF-1 levels, protein synthesis, and recovery can help the body repair muscle fibers more efficiently and respond better to strength training
CJC-1295 is a modified GHRH analogue (Growth Hormone Releasing Hormone), while Ipamorelin is a synthetic GHRP agonist (Growth Hormone Releasing Peptide)
I only incorporate therapies that are supported by clinical rationale, safety data, and appropriate sourcing through regulated pharmacies, she says
